Strategic corporate social responsibility and orphan drug development : insights from the US and the EU biopharmaceutical industry
Year of publication: |
2013
|
---|---|
Authors: | Bruyaka, Olga ; Zeitzmann, Hanko K. ; Chalamon, Isabelle ; Wokutch, Richard E. ; Thakur Wernz, Pooja |
Published in: |
Journal of business ethics : JOBE. - Dordrecht : Springer, ISSN 0167-4544, ZDB-ID 868017-6. - Vol. 117.2013, 1, p. 45-65
|
Subject: | Biopharmaceutical industry | Corporate social responsibility (CSR) | European Union (EU) | Orphan drugs | Rare diseases | Strategic CSR | United States (US) | USA | United States | Corporate Social Responsibility | Corporate social responsibility | EU-Staaten | EU countries | Pharmaindustrie | Pharmaceutical industry | Pharmakologie | Pharmacology | Arzneimittel | Pharmaceuticals | Biotechnologie-Industrie | Biotechnology industry |
-
Corporate Social Responsibility (CSR) of innovative pharmaceutical corporations : the case of BIOGEN
Witkowska, Janina, (2018)
-
Bruyaka, Olga, (2013)
-
Kim, Keungoui, (2022)
- More ...
-
Bruyaka, Olga, (2013)
-
Antecedents and relative performance of sourcing choices for new product development projects
Thakur Wernz, Pooja, (2019)
-
Reexamining CEO duality : the surprisingly problematic issues of conceptualization and measurement
Gove, Steve, (2017)
- More ...